Close Menu

This story has been updated to include investment analyst perspectives.

NEW YORK – Quidel on Thursday reported preliminary fourth quarter revenues of $808 million to $810 million, a more than fivefold increase from $152.2 million a year ago. Nevertheless, the firm's stock declined on the Nasdaq, which analysts suggested was due to revenues coming in below expectations.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Sponsored by

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints.